Press Releases

TJP Labs Press releases

TJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Application (PMTA)

 
(“TJP Labs”) is proud to announce the acceptance of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its brand, L!X nicotine pouches.

Read Full Article

TJP LABS INC. AMENDS ITS DRUG ESTABLISHMENT LICENSE AND ACHIEVES APPROVAL FOR ACTIVE PHARMACEUTICAL INGREDIENTS

TJP Labs announced that after completing a thorough regulatory assessment and meeting all GMP requirements, it received a notice of compliance for Active Pharmaceutical Ingredients (API) following an audit by the Health Canada Drug GMP Inspection Program. (“NAI”)

Read Full Article

TJP LABS INC. IS GRANTED DRUG ESTABLISHMENT LICENSING (DEL) BY HEALTH CANADA.

After completing a thorough regulatory assessment and meeting all GMP requirements, Health Canada has granted TJP Labs Inc. a Drug Establishment License (DEL).

Read Full Article

TJP LABS COMPLETES MULTI-MILLION DOLLAR INVESTMENT ROUND TO CONTINUE GLOBAL EXPANSION INTO MODERN ORAL NICOTINE MANUFACTURING

TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced its launch of Canada’s first modern oral nicotine contract manufacturing facility for buccal nicotine pouches.

Read Full Article

TJP LABS ANNOUNCES ACQUISITION OF DRUG ESTABLISHMENT LICENSED FACILITY FROM NORTH AMERICAN INGREDIENTS

TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced today that it has, through a wholly owned subsidiary, acquired certain assets of North American Ingredients Inc. (“NAI”)

Read Full Article